Direct Oral Anticoagulant Transition Strategies Using Anti-Xa Concentrations Upon Intensive Care Unit Admission. [PDF]
Sigala MI +7 more
europepmc +1 more source
Use of andexanet alfa: A British Society for Haematology position statement
British Journal of Haematology, EarlyView.
Richard J. Buka +10 more
wiley +1 more source
ABSTRACT Aim To explore healthcare professionals', patients', and family members' experiences of managing regular medications across the perioperative pathway in a specialist cancer hospital in Melbourne. Design An exploratory qualitative study using a descriptive‐interpretive approach.
Atefeh Mehrabifar +5 more
wiley +1 more source
Pericardial Effusion Associated With Direct Oral Anticoagulant Use in a Single Center Experience. [PDF]
Song J +6 more
europepmc +1 more source
Safety and Efficacy of LockeT Suture Retention Device for Large‐Bore Venous Access Closure
ABSTRACT Background Electrophysiology (EP) procedures increasingly require large‐bore venous access (LBVA), which is associated with a higher risk of vascular complications. While vascular closure devices (VCDs) are well established for arterial access, data on venous closure—particularly for LBVA—remain limited.
Pedro J. Diaz Delgado +9 more
wiley +1 more source
Assessing the knowledge and awareness of community pharmacists toward direct oral anticoagulant therapy in Saudi Arabia: A cross-sectional study. [PDF]
Basilim A.
europepmc +1 more source
Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis [PDF]
Blinder, M. +7 more
core +1 more source
Direct Oral Anticoagulant Dosing
openaire +1 more source
ABSTRACT Background The left atrial posterior wall (LAPW) is often targeted in atrial fibrillation (AF) ablation due to its shared properties with pulmonary veins. However, substrate‐guided approaches using structural markers have shown inconsistent results.
Michael M. Malaty +7 more
wiley +1 more source
Measuring Direct Oral Anticoagulant (DOAC) Levels: Applications, Limitations, and Future Directions. [PDF]
Mithoowani S, Tan CW, Siegal DM.
europepmc +1 more source

